Home
Conditions
Non-small Cell Lung Cancer

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,362 public trials 335 recruiting studies

Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

NCT00050973

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Brookwood Medical Center Birmingham, Alabama, United States

Southern Arizona VA Healthcare System Tucson, Arizona, United States

Arroyo Research Inc. Pasadena, California, United States

Desert Hematology-Oncology Medical Group, Inc. Rancho Mirage, California, United States

View all 77 locations

View Trial Details

Completed

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

NCT00756847

Conditions: Adnexal Diseases, Bronchial Neoplasms, Cancer, +27 more
Locations: Investigational Site Number St Louis, Missouri, United States

Investigational Site Number Oklahoma City, Oklahoma, United States

Investigational Site Number Houston, Texas, United States

Investigational Site Number Madison, Wisconsin, United States

View Trial Details

Completed

Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study

NCT00686465

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations: Juravinski Cancer Centre Hamilton, Ontario, Canada

London Health Sciences Centre London, Ontario, Canada

Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)

NCT00391248

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Juravinski Cancer Centre Hamilton, Ontario, Canada

Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada

View Trial Details

Completed

Study to Evaluate SID 530 Compared to Taxotere

NCT00931008

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Advanced Clinical Research Pharma Miami, Florida, United States

Gabrail Cancer Center Canton, Ohio, United States

City Cancer Hospital Vijayawada AndhraPradesh, Ch. Venkatka Krishnayya, India

Kamakshi Memorial Hospital No-1, Radial Road, Pallikarani, Chennai, Tamilnadu, India

View Trial Details

Completed

A Phase II Trial of Genexol-PM and Gemcitabine in Patients With Advanced Non-small-cell Lung Cancer

NCT01770795

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Gachon University Gil Medical Center Incheon, South Korea

View Trial Details

Completed

A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients

NCT01531790

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00050674

Conditions: Agranulocytosis, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations: The West Clinic, PC Southaven, Mississippi, United States

The West Clinic, PC Memphis, Tennessee, United States

View Trial Details

Completed

Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)

NCT00173888

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Department of Oncology, National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Completed

Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment

NCT00840125

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Meir Medical Center Kfar Saba, Israel

View Trial Details

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer trial results

Related conditions